ROSHAN CHERIAN: Open Payments
NPI 1326780552 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $128 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Luye Pharma (USA) Ltd. | 1 | $90 |
Products named: ARISTADA, FANAPT, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE.
Industry payments across TX — which companies pay providers there.
